Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

10-Q - Nektar Therapeutics | StockGist | StockGist

Companies
NKTR
10-Q

Home Top Movers Companies Concepts

Home Filings NKTR10-Q

10-Q

Periodic Report

Nektar Therapeutics

Filed Nov 7, 2025

Accepted Nov 6, 2025, 7:00 PM ET

CIK 0000906709

View on SEC.gov Company Profile

Key Facts

Fiscal Year

2025

Period

Q3

Period End

Sep 30, 2025

Recent Filings

Nektar Therapeutics1 weeks ago

Nektar Therapeutics3 weeks ago

Nektar Therapeutics3 weeks ago

Nektar Therapeutics1 months ago

Nektar Therapeutics1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice